BioNTech SE is 21.8x more valuable than Cullinan Therapeutics, Inc. by market capitalization ($21.79 B vs $1.00 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CGEM | BNTX |
|---|---|---|
| Market cap | $1.00 B | $21.79 B |
| US-listed rank | #2637 | #587 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$219.88M | - |
| SEC filings | 435 | 548 |
BioNTech SE is 21.8x more valuable than Cullinan Therapeutics, Inc. by market capitalization ($21.79 B vs $1.00 B).
Full pages: Cullinan Therapeutics, Inc. and BioNTech SE, or browse the full rankings.